Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9EKF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,528
Award facts
- Contract value 100% obligated
- $11,527.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,527.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx Unoready 300 mg pen 2ml, a pharmaceutical product for immunological treatment. The contract, awarded on February 4, 2026, with an ultimate completion date of February 5, 2026, represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order was competitively awarded with no set-aside designation, reflecting the vendor's demonstrated capability to meet federal procurement requirements through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government agencies including the Department of Defense and Department of Veterans Affairs. The parent company holds a significant $999.99 billion IDC with DLA Troop Support Medical through December 2031, which serves as the overarching contract vehicle enabling delivery of comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order exemplifies the company's ongoing role in supplying specialty medications and brand-name pharmaceuticals to federal medical institutions and military treatment facilities.
Quick answers
Who was awarded contract SPE2DR26F9EKF?
SPE2DR26F9EKF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F9EKF worth?
The government has obligated $11,528 on SPE2DR26F9EKF.
Is contract SPE2DR26F9EKF an order under another contract?
Yes. SPE2DR26F9EKF is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9EKF competed?
The extent of competition for SPE2DR26F9EKF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award